Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
De novo monoallelic Reelin missense variants cause dominant neuronal migration disorders via a dominant-negative mechanism
Martina Riva, … , Nadia Bahi-Buisson, Alessandra Pierani
Martina Riva, … , Nadia Bahi-Buisson, Alessandra Pierani
Published July 9, 2024
Citation Information: J Clin Invest. 2024;134(16):e153097. https://doi.org/10.1172/JCI153097.
View: Text | PDF
Research Article Development Neuroscience

De novo monoallelic Reelin missense variants cause dominant neuronal migration disorders via a dominant-negative mechanism

  • Text
  • PDF
Abstract

Reelin (RELN) is a secreted glycoprotein essential for cerebral cortex development. In humans, recessive RELN variants cause cortical and cerebellar malformations, while heterozygous variants were associated with epilepsy, autism, and mild cortical abnormalities. However, the functional effects of RELN variants remain unknown. We identified inherited and de novo RELN missense variants in heterozygous patients with neuronal migration disorders (NMDs) as diverse as pachygyria and polymicrogyria. We investigated in culture and in the developing mouse cerebral cortex how different variants impacted RELN function. Polymicrogyria-associated variants behaved as gain-of-function, showing an enhanced ability to induce neuronal aggregation, while those linked to pachygyria behaved as loss-of-function, leading to defective neuronal aggregation/migration. The pachygyria-associated de novo heterozygous RELN variants acted as dominant-negative by preventing WT RELN secretion in culture, animal models, and patients, thereby causing dominant NMDs. We demonstrated how mutant RELN proteins in vitro and in vivo predict cortical malformation phenotypes, providing valuable insights into the pathogenesis of such disorders.

Authors

Martina Riva, Sofia Ferreira, Kotaro Hayashi, Yoann Saillour, Vera P. Medvedeva, Takao Honda, Kanehiro Hayashi, Claire Altersitz, Shahad Albadri, Marion Rosello, Julie Dang, Malo Serafini, Frédéric Causeret, Olivia J. Henry, Charles-Joris Roux, Céline Bellesme, Elena Freri, Dragana Josifova, Elena Parrini, Renzo Guerrini, Filippo Del Bene, Kazunori Nakajima, Nadia Bahi-Buisson, Alessandra Pierani

×

Figure 2

Missense variants alter RELN secretion in vitro.

Options: View larger image (or click on image) Download as PowerPoint
Missense variants alter RELN secretion in vitro.
(A) Schematic of the fu...
(A) Schematic of the full-length (FL) RELN protein (450 kDa), its N-t and C-t cleavage sites (dashed arrows), and its 5 cleaved products (NR6, R3-8, R3-6, NR2, R7-8). The binding regions of the 142 and G10 antibodies and the position of RELN variants in the patient color coding are indicated with arrowheads and arrows, respectively. (B and C) Immunoblots (left) and densitometric analysis (right) of HEK293T cell lysates (B) and media (C) transfected with either WT-RELN or RELN variants, probed with anti-RELN G10 or anti-GFP antibodies. RELN signal normalized to GFP in lysates (n = 5–7 independent transfections) and expressed as the media-to-lysate (M/L) ratio in the media (n = 4–6 independent transfections). Data are mean ± SEM; 2-tailed 1-sample t test, *P < 0.05, **P < 0.01, ***P < 0.001. kDa, protein standard sizes.

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts